These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy. Hellmann MA; Lev N; Lotan I; Mosberg-Galili R; Inbar E; Luckman J; Fichman-Horn S; Yakimov M; Steiner I J Neurol Sci; 2014 Sep; 344(1-2):193-7. PubMed ID: 25001515 [TBL] [Abstract][Full Text] [Related]
104. Extent of secondary intraventricular hemorrhage is an independent predictor of outcomes in intracerebral hemorrhage: data from the Helsinki ICH Study. Mustanoja S; Satopää J; Meretoja A; Putaala J; Strbian D; Curtze S; Haapaniemi E; Sairanen T; Niemelä M; Kaste M; Tatlisumak T Int J Stroke; 2015 Jun; 10(4):576-81. PubMed ID: 25580771 [TBL] [Abstract][Full Text] [Related]
105. Ketoconazole increases fingolimod blood levels in a drug interaction via CYP4F2 inhibition. Kovarik JM; Dole K; Riviere GJ; Pommier F; Maton S; Jin Y; Lasseter KC; Schmouder RL J Clin Pharmacol; 2009 Feb; 49(2):212-8. PubMed ID: 19118083 [TBL] [Abstract][Full Text] [Related]
106. Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial. Rincon F; Friedman DP; Bell R; Mayer SA; Bray PF Int J Stroke; 2014 Jul; 9(5):646-51. PubMed ID: 24450819 [TBL] [Abstract][Full Text] [Related]
107. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury. Lee KD; Chow WN; Sato-Bigbee C; Graf MR; Graham RS; Colello RJ; Young HF; Mathern BE J Neurotrauma; 2009 Dec; 26(12):2335-44. PubMed ID: 19624262 [TBL] [Abstract][Full Text] [Related]
108. Reassessment of defibrase in treatment of acute cerebral infarction: a multicenter, randomized, double-blind, placebo-controlled trial. Cooperative Group for Reassessment of Defibrase Chin Med Sci J; 2005 Sep; 20(3):151-8. PubMed ID: 16261883 [TBL] [Abstract][Full Text] [Related]
109. Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis. Fox E; Edwards K; Burch G; Wynn DR; LaGanke C; Crayton H; Hunter SF; Huffman C; Kim E; Pestreich L; McCague K; Barbato L; Mult Scler Relat Disord; 2014 Sep; 3(5):607-19. PubMed ID: 26265273 [TBL] [Abstract][Full Text] [Related]
110. Reduced Intracerebral Hemorrhage and Perihematomal Edema Volumes in Diabetics on Sulfonylureas. Irvine H; Male S; Robertson J; Bell C; Bentho O; Streib C Stroke; 2019 Apr; 50(4):995-998. PubMed ID: 30879436 [TBL] [Abstract][Full Text] [Related]
111. Association between seizures and outcomes among intracerebral hemorrhage patients: the China National Stroke Registry. Li Z; Zhao X; Wang Y; Wang C; Liu L; Shao X; Wang W; Pan Y; Wang C; Ji R; Zhang C; Jing J; Wang Y J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):455-64. PubMed ID: 25511617 [TBL] [Abstract][Full Text] [Related]
117. Nuclear factor-κB activation in perihematomal brain tissue correlates with outcome in patients with intracerebral hemorrhage. Zhang ZL; Liu YG; Huang QB; Wang HW; Song Y; Xu ZK; Li F J Neuroinflammation; 2015 Mar; 12():53. PubMed ID: 25889503 [TBL] [Abstract][Full Text] [Related]
118. Intraventricular fibrinolysis does not increase perihemorrhagic edema after intracerebral hemorrhage. Volbers B; Wagner I; Willfarth W; Doerfler A; Schwab S; Staykov D Stroke; 2013 Feb; 44(2):362-6. PubMed ID: 23306318 [TBL] [Abstract][Full Text] [Related]